PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Market Analysis and Trades for 12/2

PharmD_KS's avatar
PharmD_KS
Dec 01, 2025
∙ Paid

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so the Discord option includes Substack content but a new Substack subscription does not include Discord access.

Be sure you have read the Starter Kit, including the free section even if you’re a paid subscriber. Trading Doggy Style Starter Kit

The weekly post for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. It can be found here Market Analysis for the Week of 11/30

After the nasty Sunday night open (on NQ in particular) Friday’s spike (6857-6864) was rejected. My bias from the weekly plan was that Friday’s low (6831.25) would be taken out, and 6824 would be seen bringing the daily timeframe back into balance from active trend.

The spike was rejected and ultimately resolved to 6802 at the overnight low. Buyers recovered and opened just above 6809.5-6812.5 on a true gap down (below the prior day’s RTH low). From there we just play the rules of a true gap down, for which the following applied:

Notice the opening drive higher, and two subsequent tests of the open and 5-minute opening range low which held. The first test produced a nice long straight to the weekly 41-45 level. It rejected soundly, but sellers still found no traction below the open. This ultimately led to a break of 41-44 but bulls ran out of gas just shy of Friday’s spike.

This new multi-day balance will now determine if a daily higher low is produced to continue higher for an ATH retest, or if more of last week’s move is given back. In tonight’s plan I’ll discuss the current and prospective edges for this balance and how I’ll trade it.

Paid Content Below or in the Discord

JOIN THE DISCORD

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 PharmD_KS · Market data by Intrinio · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture